… the program has educated and engaged more than 900 doctors from around the world. Participant feedback is consistently … care and research in that area. Because training varies from center to center, some residents receive limited or … held in October in Phoenix, Arizona, drew 92 attendees from across North, South and Central America. The program …

… difference. KV: How different are your responsibilities now from when you started? CG: It has been quite a journey. I … support them. I also had to learn how to answer questions from the public. We had so many calls from people with Parkinson's and their families asking for …

… to dig into this effort with immeasurable dedication. From 50-mile ultramarathons to international film festivals, … single-day fundraising event for the third year in a row!  From humble beginnings and 27 cyclists in year one, the New … welcomed 904 cyclists—each covering distances ranging from 10 to 75 miles—and collectively raised over $825,000. …

… loses steam, and is unable to secure the necessary support from the pharmaceutical industry to move research from the laboratory and into the clinic. Conn and Surmeier, … researchers in their shoes, knew that without a push from the right source, their ideas risked falling prey to …

… study. “The drug used in the trial is the same exact drug from Novartis that people have used to quit smoking for many … She is hopeful that her team could have high level results from NIC-PD by spring of 2015. A best case scenario: The … could protect dopamine-producing neurons in the brain from dying. But we’ve yet to see this effect in people. …

… Today researchers from the Parkinson's Progression Markers Initiative (PPMI) … cohort. They analyzed cerebrospinal fluid (CSF) from 173 people recently diagnosed with Parkinson's and 112 … at alpha-synuclein CSF levels over three years, including from the prodromal cohort: people with Parkinson's risk …